• We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need optimized assays for investigational toxicology.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.

  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

OrganoStart™ Pro

The all-in-one solution to efficiently start using 3D human tissue models.

 


Establishing 3D human tissue models is often a complex and time-consuming task. The OrganoStart Pro package simplifies this process, providing everything needed to initiate 3D cell culture studies combined with assessment of barrier integrity using Trans Epithelial Electrical Resistance (TEER) with the OrganoTEER® system. This ready-to-use solution enables efficient, high-throughput analysis, simplifying your in vitro drug studies in 3D tissue models.

 

The OrganoStart Pro package includes:

 

Flyer: The OrganoStart Pro Request Quote

Accelerate Your Drug Testing with 3D Organoid Models

Elevate your research with the OrganoReady® Colon Organoid and OrganoTEER® device. Our pre-made, adult stem cell-derived colon model, paired with real-time barrier function monitoring, offers accurate and high-throughput evaluation of drug toxicity. This streamlined approach provides both scalability and precision, enabling you to initiate experiments with efficiency.

The OrganoReady Colon Organoid offers a more translatable solution compared to other cell-based models, providing accurate predictions of drug responses. The Colon Organoid model features tubular structures of the colon with accessible apical and basolateral sides, and fluid perfusion through the lumen, which enables direct compound exposure, closely mimicking oral and intravenous drug administration.

A perfusable Colon Organoid tubule with accessible apical and basolateral side, stained for tight junction (Occludin, green) and nuclei (blue).

Discover the Colon Organoid model Explore the Colon Organoid package

Explore our OrganoReady models

Ready-to-use 3D Tissue Models Shipped to Your Laboratory

 

  • The Colon Organoid model: this adult stem cell-derived colon organoid model enables more accurate prediction of gastrointestinal toxicity.

  • The Colon Caco-2 model: this polarized colon Caco-2 model is designed to screen compounds to predict gastrointestinal toxicity.

  • The BBB HBMEC model: this primary human BBB model is designed for investigative toxicology applications.

  • The Angiogenesis HUVEC model: the angiogenesis model with perfusable microvessels is designed to study compound toxicity, and directional modulation of angiogenesis.

Want to know more?


Get up to speed with 3D tissue culture and learn how our OrganoReady® models can supports your research needs.

Read our publications, application notes, watch our webinars, or check out the supporting protocols.
All compiled for you, by our scientists.

Explore Our Publications FAQ

Cookies

May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy
Accept all
Accept selected
Decline all